King's College London

Research portal

Potential Mechanisms of Mitochondrial DNA mediated Acquired Mitochondrial Disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationMitochondrial Biology and Experimental Therapeutics
EditorsPaulo Oliveiro
PublisherSpringer Nature
Chapter14
Pages297-315
Volume1
Edition1
ISBN (Electronic)9783319733449
ISBN (Print)9783319733432
DOIs
Publication statusPublished - Mar 2018

Documents

King's Authors

Abstract

Mitochondria are cellular organelles which contain mitochondrial DNA (MtDNA) in the form of an extranuclear genome. MtDNA can be present in 100s to thousands to copies per cell in the body depending on the bioenergetic requirements of the host cell. MtDNA encodes subunits of the electron transport chain and therefore is required to produce cellular energy in the form of ATP. However MtDNA can also act as an inflammatory molecule since it resembles bacterial DNA, resulting in activation of pathways leading to enhanced cytokine production and chronic inflammation. In the current chapter, we suggest that MtDNA mediated mechanisms that cause systemic mitochondrial dysfunction are involved in many common dieases not traditionally recognised as mitochondrial disease, and we suggest that such disorders could be considered as “acquired mitochondrial diseases”, distinct from primary and secondary mitochondrial disease. Aquired mitochondrial diseases include cardiovascular and neurodegenerative disease as well as diabetic complications, and are associated with oxidative stress and sterile/chronic inflammation in their pathophysiology. We propose a mechanism of how systemic damage to MtDNA, mediated through oxidative stress, can cause inflammation and bioenergetic deficit. Some recent evidence of the proposed mechanism is provided for diabetic nephropathy, a complication of diabetes, which has not traditionally been regarded as a disease of mitochondrial dysfunction. According to the hypothesis proposed, it may be possible to use MtDNA levels in body fluids or cells to predict risk of aquired diseases of mitochondrial dysfunction, and to design novel therapies targetting the specific MtDNA mediated pathways.

Download statistics

No data available

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454